Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.

Steinkellner T, Zell V, Farino ZJ, Sonders MS, Villeneuve M, Freyberg RJ, Przedborski S, Lu W, Freyberg Z, Hnasko TS.

J Clin Invest. 2018 Feb 1;128(2):774-788. doi: 10.1172/JCI95795. Epub 2018 Jan 16.

2.

Neuronal Depolarization Drives Increased Dopamine Synaptic Vesicle Loading via VGLUT.

Aguilar JI, Dunn M, Mingote S, Karam CS, Farino ZJ, Sonders MS, Choi SJ, Grygoruk A, Zhang Y, Cela C, Choi BJ, Flores J, Freyberg RJ, McCabe BD, Mosharov EV, Krantz DE, Javitch JA, Sulzer D, Sames D, Rayport S, Freyberg Z.

Neuron. 2017 Aug 30;95(5):1074-1088.e7. doi: 10.1016/j.neuron.2017.07.038. Epub 2017 Aug 17.

3.

Fluorescent false neurotransmitter reveals functionally silent dopamine vesicle clusters in the striatum.

Pereira DB, Schmitz Y, Mészáros J, Merchant P, Hu G, Li S, Henke A, Lizardi-Ortiz JE, Karpowicz RJ Jr, Morgenstern TJ, Sonders MS, Kanter E, Rodriguez PC, Mosharov EV, Sames D, Sulzer D.

Nat Neurosci. 2016 Apr;19(4):578-86. doi: 10.1038/nn.4252. Epub 2016 Feb 22.

4.

Mechanisms of amphetamine action illuminated through optical monitoring of dopamine synaptic vesicles in Drosophila brain.

Freyberg Z, Sonders MS, Aguilar JI, Hiranita T, Karam CS, Flores J, Pizzo AB, Zhang Y, Farino ZJ, Chen A, Martin CA, Kopajtic TA, Fei H, Hu G, Lin YY, Mosharov EV, McCabe BD, Freyberg R, Wimalasena K, Hsin LW, Sames D, Krantz DE, Katz JL, Sulzer D, Javitch JA.

Nat Commun. 2016 Feb 16;7:10652. doi: 10.1038/ncomms10652.

5.

Loss of Striatonigral GABAergic Presynaptic Inhibition Enables Motor Sensitization in Parkinsonian Mice.

Borgkvist A, Avegno EM, Wong MY, Kheirbek MA, Sonders MS, Hen R, Sulzer D.

Neuron. 2015 Sep 2;87(5):976-88. doi: 10.1016/j.neuron.2015.08.022.

6.

Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Tang G, Gudsnuk K, Kuo SH, Cotrina ML, Rosoklija G, Sosunov A, Sonders MS, Kanter E, Castagna C, Yamamoto A, Yue Z, Arancio O, Peterson BS, Champagne F, Dwork AJ, Goldman J, Sulzer D.

Neuron. 2014 Sep 3;83(5):1131-43. doi: 10.1016/j.neuron.2014.07.040. Epub 2014 Aug 21. Erratum in: Neuron. 2014 Sep 17;83(6):1482.

7.

New fluorescent substrate enables quantitative and high-throughput examination of vesicular monoamine transporter 2 (VMAT2).

Hu G, Henke A, Karpowicz RJ Jr, Sonders MS, Farrimond F, Edwards R, Sulzer D, Sames D.

ACS Chem Biol. 2013 Sep 20;8(9):1947-54. doi: 10.1021/cb400259n. Epub 2013 Jul 16.

8.

Fluorescent dopamine tracer resolves individual dopaminergic synapses and their activity in the brain.

Rodriguez PC, Pereira DB, Borgkvist A, Wong MY, Barnard C, Sonders MS, Zhang H, Sames D, Sulzer D.

Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):870-5. doi: 10.1073/pnas.1213569110. Epub 2012 Dec 31.

9.

Dopamine transport by the serotonin transporter: a mechanistically distinct mode of substrate translocation.

Larsen MB, Sonders MS, Mortensen OV, Larson GA, Zahniser NR, Amara SG.

J Neurosci. 2011 Apr 27;31(17):6605-15. doi: 10.1523/JNEUROSCI.0576-11.2011.

10.

Two allelic isoforms of the serotonin transporter from Schistosoma mansoni display electrogenic transport and high selectivity for serotonin.

Fontana AC, Sonders MS, Pereira-Junior OS, Knight M, Javitch JA, Rodrigues V, Amara SG, Mortensen OV.

Eur J Pharmacol. 2009 Aug 15;616(1-3):48-57. doi: 10.1016/j.ejphar.2009.06.023. Epub 2009 Jun 21.

11.

Trace amine-associated receptor 1 displays species-dependent stereoselectivity for isomers of methamphetamine, amphetamine, and para-hydroxyamphetamine.

Reese EA, Bunzow JR, Arttamangkul S, Sonders MS, Grandy DK.

J Pharmacol Exp Ther. 2007 Apr;321(1):178-86. Epub 2007 Jan 11.

PMID:
17218486
12.

Mechanisms of neurotransmitter release by amphetamines: a review.

Sulzer D, Sonders MS, Poulsen NW, Galli A.

Prog Neurobiol. 2005 Apr;75(6):406-33. Review.

PMID:
15955613
13.

How did the neurotransmitter cross the bilayer? A closer view.

Sonders MS, Quick M, Javitch JA.

Curr Opin Neurobiol. 2005 Jun;15(3):296-304. Review.

PMID:
15919190
14.

Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.

Wang W, Sonders MS, Ukairo OT, Scott H, Kloetzel MK, Surratt CK.

Mol Pharmacol. 2003 Aug;64(2):430-9.

PMID:
12869648
15.

Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.

Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, Quigley DI, Darland T, Suchland KL, Pasumamula S, Kennedy JL, Olson SB, Magenis RE, Amara SG, Grandy DK.

Mol Pharmacol. 2001 Dec;60(6):1181-8.

PMID:
11723224
16.

The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.

Pörzgen P, Park SK, Hirsh J, Sonders MS, Amara SG.

Mol Pharmacol. 2001 Jan;59(1):83-95.

PMID:
11125028
17.

Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor.

Wong EH, Sonders MS, Amara SG, Tinholt PM, Piercey MF, Hoffmann WP, Hyslop DK, Franklin S, Porsolt RD, Bonsignori A, Carfagna N, McArthur RA.

Biol Psychiatry. 2000 May 1;47(9):818-29.

PMID:
10812041
18.

Arachidonic acid elicits a substrate-gated proton current associated with the glutamate transporter EAAT4.

Fairman WA, Sonders MS, Murdoch GH, Amara SG.

Nat Neurosci. 1998 Jun;1(2):105-13.

PMID:
10195124
19.

Neurotransmitter transporters as molecular targets for addictive drugs.

Amara SG, Sonders MS.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):87-96. Review.

PMID:
9716932
20.

Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.

Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C, Waldegger S, Lang F, Koepsell H.

Mol Pharmacol. 1998 Aug;54(2):342-52.

PMID:
9687576
21.

Molecular physiology and regulation of catecholamine transporters.

Amara SG, Sonders MS, Zahniser NR, Povlock SL, Daniels GM.

Adv Pharmacol. 1998;42:164-8. No abstract available.

PMID:
9327869
22.

Activation of protein kinase C inhibits uptake, currents and binding associated with the human dopamine transporter expressed in Xenopus oocytes.

Zhu SJ, Kavanaugh MP, Sonders MS, Amara SG, Zahniser NR.

J Pharmacol Exp Ther. 1997 Sep;282(3):1358-65.

PMID:
9316847
23.

Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants.

Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG.

J Neurosci. 1997 Feb 1;17(3):960-74.

24.

Channels in transporters.

Sonders MS, Amara SG.

Curr Opin Neurobiol. 1996 Jun;6(3):294-302. Review.

PMID:
8794089
25.

Radiosynthesis of sigma receptor ligands for positron emission tomography: 11C- and 18F-labeled guanidines.

Wilson AA, Dannals RF, Ravert HT, Sonders MS, Weber E, Wagner HN Jr.

J Med Chem. 1991 Jun;34(6):1867-70.

PMID:
1648140
26.

Synthesis and structure-activity relationships of N,N'-di-o-tolylguanidine analogues, high-affinity ligands for the haloperidol-sensitive sigma receptor.

Scherz MW, Fialeix M, Fischer JB, Reddy NL, Server AC, Sonders MS, Tester BC, Weber E, Wong ST, Keana JF.

J Med Chem. 1990 Sep;33(9):2421-9.

PMID:
1975275
27.

A novel photoaffinity ligand for the phencyclidine site of the N-methyl-D-aspartate receptor labels a Mr 120,000 polypeptide.

Sonders MS, Barmettler P, Lee JA, Kitahara Y, Keana JF, Weber E.

J Biol Chem. 1990 Apr 25;265(12):6776-81.

29.

Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action.

Sonders MS, Keana JF, Weber E.

Trends Neurosci. 1988 Jan;11(1):37-40. Review. No abstract available.

PMID:
2469154
30.

Synthesis and characterization of an affinity label for brain receptors to psychotomimetic benzomorphans: differentiation of sigma-type and phencyclidine receptors.

Adams JT, Teal PM, Sonders MS, Tester B, Esherick JS, Scherz MW, Keana JF, Weber E.

Eur J Pharmacol. 1987 Oct 6;142(1):61-71.

PMID:
2826177

Supplemental Content

Loading ...
Support Center